Scott Berry, Roxanne Cosby, Timothy R. Asmis, Kelvin Chan et al.
Background An important goal of intermittent strategies of delivering systemic treatment as first-line treatment of metastatic colorectal cancer (mCRC) is to maintain efficacy while improving patients' quality of life (QoL). Given the varying impact on efficacy demonstrated in individual randomized,...
Adam Fundytus, Wilma M. Hopman, Nazik Hammad, James Biagi et al.
Background: In 2000, a Canadian task force recommended that medical oncologists (MOS) meet a target of 160–175 new patient consultations per year. Here, we report the Canadian results of a global survey of mo workload compared with mo workload in other high-income countries (HICS). Methods: Using a ...
Khalid El Bairi, Salma Najem, Arman Reza Chowdhury, Abeid Omar et al.
9002 Background: Conflicts of interest (COI) between oncologists and the pharmaceutical industry might considerably influence how the presentation of the research results is delivered, impacting treatment decisions, and policy-making.While there are regulations on reporting COI in high-income countr...
Khalid El Bairi, D. Trapani, S.J. Nidhamalddin, S. Zeb Khan et al.
Journals: A Global Survey Khalid El Bairi (1), Dario Trapani, Sara Jamil Nidhamalddin, Shah Zeb Khan, Arman Reza Chowdhury, Csongor György Lengyel, Sadaqat Hussain, Baker Shalal Habeeb, Angelica Petrillo, Nabil Elhadi Omar, Sara Altuna, Fahmi Usman Seid, Essam Elfaham, Andreas Seeber, Felipe Roitber...